耐喹诺酮的耐甲氧西林金黄色葡萄球菌菌株
Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.
作者信息
Schaefler S
机构信息
Bureau of Laboratories, New York City Department of Health, New York.
出版信息
J Clin Microbiol. 1989 Feb;27(2):335-6. doi: 10.1128/jcm.27.2.335-336.1989.
Abstract
Since January 1988, Staphylococcus aureus strains with a high level of quinolone resistance have been isolated at 17 hospitals and 15 nursing homes in New York City. The majority of these strains were methicillin resistant. The bacteriophage types and susceptibility to other antibiotics were similar to those of quinolone-susceptible strains isolated at the same hospitals.
摘要
自1988年1月以来，纽约市17家医院和15家疗养院分离出了对喹诺酮具有高度耐药性的金黄色葡萄球菌菌株。这些菌株大多数对甲氧西林耐药。其噬菌体类型及对其他抗生素的敏感性与在同一些医院分离出的喹诺酮敏感菌株相似。
相似文献
1
Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.耐喹诺酮的耐甲氧西林金黄色葡萄球菌菌株
J Clin Microbiol. 1989 Feb;27(2):335-6. doi: 10.1128/jcm.27.2.335-336.1989.
2
Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.氟罗沙星在实验性耐甲氧西林金黄色葡萄球菌心内膜炎中的疗效。
Antimicrob Agents Chemother. 1989 Apr;33(4):519-21. doi: 10.1128/AAC.33.4.519.
3
Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.一家综合医院中耐甲氧西林金黄色葡萄球菌分离株对喹诺酮类药物的广泛耐药性
Antimicrob Agents Chemother. 1989 Apr;33(4):593-4. doi: 10.1128/AAC.33.4.593.
4
Staphylococcus aureus resistance to antibiotics and spread of phage types.金黄色葡萄球菌对抗生素的耐药性及噬菌体类型的传播。
Medicina (Kaunas). 2006;42(4):332-9.
5
Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.耐甲氧西林和庆大霉素的金黄色葡萄球菌对环丙沙星的耐药性
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):622-4. doi: 10.1007/BF01968141.
6
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group.1988年纽约医疗机构中耐环丙沙星的耐甲氧西林金黄色葡萄球菌。纽约耐甲氧西林金黄色葡萄球菌研究小组。
Am J Public Health. 1990 Jul;80(7):810-3. doi: 10.2105/ajph.80.7.810.
7
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.一家急症医院中对环丙沙星耐药的耐甲氧西林金黄色葡萄球菌
Antimicrob Agents Chemother. 1990 Nov;34(11):2050-4. doi: 10.1128/AAC.34.11.2050.
8
Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals.纽约市医院中出现对庆大霉素和甲氧西林耐药的金黄色葡萄球菌菌株。
J Clin Microbiol. 1981 Apr;13(4):754-9. doi: 10.1128/jcm.13.4.754-759.1981.
9
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.针对耐甲氧西林和/或耐庆大霉素及敏感葡萄球菌的新型药物。
Chemotherapy. 1989;35(5):333-7. doi: 10.1159/000238691.
10
In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.
J Antimicrob Chemother. 1988 Oct;22 Suppl D:35-41. doi: 10.1093/jac/22.supplement_d.35.
引用本文的文献
1
and Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor.新型细菌 DNA 拓扑异构酶/拓扑异构酶 IV 抑制剂 CUO246 的性质。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0092122. doi: 10.1128/aac.00921-22. Epub 2022 Nov 30.
2
Comparison between the effect of Lawsonia inermis and flubendazole on Strongyloides species using scanning electron microscopy.使用扫描电子显微镜比较无刺番荔枝和氟苯达唑对类圆线虫的作用。
J Parasit Dis. 2016 Jun;40(2):415-22. doi: 10.1007/s12639-014-0519-2. Epub 2014 Aug 24.
3
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.葡萄球菌中的耐甲氧西林特性：分子与生化基础及临床意义
Clin Microbiol Rev. 1997 Oct;10(4):781-91. doi: 10.1128/CMR.10.4.781.
4
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.喹诺酮类药物的亲水性并非金黄色葡萄球菌外排介导耐药突变体活性降低的唯一因素。
Antimicrob Agents Chemother. 1996 Aug;40(8):1835-42. doi: 10.1128/AAC.40.8.1835.
5
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus.负责金黄色葡萄球菌喹诺酮耐药性的DNA拓扑异构酶IV grlA基因的改变。
Antimicrob Agents Chemother. 1996 May;40(5):1157-63. doi: 10.1128/AAC.40.5.1157.
6
Epidemiology of quinolone resistance: Europe and North and South America.喹诺酮耐药性的流行病学：欧洲及南北美洲
Drugs. 1995;49 Suppl 2:36-42. doi: 10.2165/00003495-199500492-00007.
7
Lomefloxacin clinical pharmacokinetics.洛美沙星的临床药代动力学。
Clin Pharmacokinet. 1993 Jul;25(1):6-19. doi: 10.2165/00003088-199325010-00002.
8
Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.每日一次芦氟沙星与每日两次氧氟沙星治疗复杂性膀胱炎和上尿路感染。意大利多中心泌尿道感染芦氟沙星研究组
Infection. 1993 Mar-Apr;21(2):106-11. doi: 10.1007/BF01710743.
9
A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.培氟沙星与替考拉宁治疗癌症患者革兰氏阳性球菌感染的前瞻性随机研究：因对氟喹诺酮类药物产生耐药性而提前终止
Support Care Cancer. 1994 May;2(3):191-6. doi: 10.1007/BF00417480.
10
Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.铜绿假单胞菌和金黄色葡萄球菌中的喹诺酮耐药性。治疗期间的发展及临床意义。
Infection. 1994;22 Suppl 2:S111-21. doi: 10.1007/BF01793575.
本文引用的文献
1
Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals.纽约市医院中出现对庆大霉素和甲氧西林耐药的金黄色葡萄球菌菌株。
J Clin Microbiol. 1981 Apr;13(4):754-9. doi: 10.1128/jcm.13.4.754-759.1981.
2
Methicillin-resistant Staphylococcus aureus strains in New York City hospitals: inter-hospital spread of resistant strains of type 88.纽约市医院中的耐甲氧西林金黄色葡萄球菌菌株：88型耐药菌株的医院间传播
J Clin Microbiol. 1984 Sep;20(3):536-8. doi: 10.1128/jcm.20.3.536-538.1984.
3
Bacterial resistance to fluoroquinolones.
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S57-63. doi: 10.1093/clinids/10.supplement_1.s57.
4
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.A-56619、A-56620、阿米氟沙星、环丙沙星、依诺沙星、诺氟沙星和氧氟沙星对耐甲氧西林金黄色葡萄球菌的体外比较
Antimicrob Agents Chemother. 1986 Feb;29(2):325-6. doi: 10.1128/AAC.29.2.325.
5
The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.诺氟沙星、环丙沙星、依诺沙星和萘啶酸对从住院感染患者中分离出的423株革兰氏阴性杆菌和葡萄球菌的体外比较活性。
J Antimicrob Chemother. 1986 Jan;17(1):63-7. doi: 10.1093/jac/17.1.63.
Zotero 插件